Securities Code: 301507 Securities Abbreviation: Minsheng Health Announcement No.: 2026-028
Hangzhou Minsheng Health Pharmaceutical Co., Ltd.
Announcement on the Progress of the Second Share Repurchase by Centralized Bidding
The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Key Information Prompt: ● Progress of the Second Repurchase Plan: As of April 30, 2026, Hangzhou Minsheng Health Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has cumulatively repurchased 2,105,100 shares through a dedicated securities account for repurchases, using the centralized bidding transaction method. This represents 0.59% of the Company's total share capital. The highest transaction price was 15.67 yuan/share, the lowest transaction price was 14.22 yuan/share, and the payment amount was 31,476,595 yuan (excluding transaction fees).
I. Basic Information on Share Repurchase